Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Subclinical Atherosclerosis in Chinese Subjects
CTR20150618Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosuvastatin in atherosclerosis, sponsored by AstraZeneca. Started Sep 2015; status: completed.
02
Drugs
rosuvastatin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on CTR20150618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150618.